Document is current

Any future updates will be listed below

G-BA attestiert Dupilumab beträchtlichen Zusatznutzen

Crossref DOI link: https://doi.org/10.1007/s00060-020-7442-1

Published Online: 2021-02-26

Published Print: 2021-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark